ストックスクリーナーアプリを入手
5.25
2.34%
0.12
Polypid Ltd (PYPD) 最新ニュース
PolyPid to Present D-PLEX₁₀₀ Microbiology Data at IDWeek 2026 - GlobeNewswire Inc.
PolyPid Ltd.Ordinary Shares (Nasdaq:PYPD) Stock Quote - The Chronicle-Journal
PYPD Q2 2026 Earnings: PolyPid Posts Narrower-Than-Expected Loss With No Reported RevenueFinancial Data - dars.gov.et
PolyPid (PYPD): Will The November FDA Decision Propel The Stock? - RTTNews
PolyPid (PYPD) Stock: Finishes 0.59% Up at $5.13 in the Current Update; Trading Range - vinanet.vn
PolyPid (PYPD) Stock: Finishes 0.59% Up at $5.13 in the Current Update; Trading Range - dars.gov.et
PolyPid (PYPD) Stock: Finishes 0.59% Up at $5.13 in the Current Update; Trading Range - dars.gov.et
PolyPid (PYPD) Stock: Finishes 0.59% Up at $5.13 in the Current Update; Trading Range - www.dars.gov.et
PolyPid (PYPD) Q2 2026 Results: Profit Per Share Surpasses Its Benchmark in the Current Update; Closing Reaction: Shares Close 1.40% Higher in Latest TradingRetail Earnings Report - vinanet.vn
PolyPid | 3: Initial statement of beneficial ownership of securities- Warshavsky Ori - Moomoo
PolyPid | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16] - Moomoo
PolyPid (PYPD) Q2 2026 Results: Profit Per Share Surpasses Its Benchmark in the Current Update; Closing Reaction - dars.gov.et
PolyPid (PYPD) Q2 2026 Results: Profit Per Share Surpasses Its Benchmark in the Current Update; Closing Reaction: Shares Close 1.40% Higher in Latest TradingEarnings Season Preview - dars.gov.et
AIGH Capital Management LLC Purchases Shares of 1,504,741 PolyPid Ltd. $PYPD - MarketBeat
PolyPid Ltd (PYPD) Stock News Today - TradingKey
PolyPid Ltd. (PYPD) Holds Near $4.75 as Clinical-Stage Biotech Navigates Key Support ZoneCall Resistance - vinanet.vn
Conferencia de resultados del 2T de 2026 de PolyPid (PYPD): revisión prioritaria de D-PLEX100 y acuerdo con Azurity - TradingKey
What is HC Wainwright's Forecast for PolyPid Q3 Earnings? - MarketBeat
PolyPid (PYPD) Earnings Call zum 2. Quartal 2026: Prioritäre Prüfung für D-PLEX100 und Azurity-Deal - TradingKey
PolyPid Ltd. (PYPD) Holds Near $4.75 as Clinical-Stage Biotech Navigates Key Support ZoneRisk Reversal - dars.gov.et
LanzaTech Global Warrant (LNZAW) Holds Steady at $0.02 as Support and Resistance ConvergeExtension Target - dars.gov.et
Roth MKM Maintains PolyPid(PYPD.US) With Buy Rating, Cuts Target Price to $8 - Moomoo
PolyPid (PYPD) investors disclose up to 13.4% beneficial stake via complex structure - Stock Titan
PolyPid Ltd. (PYPD) Slips 2.27% to $4.73 as Shares Test Key Support ZoneBollinger Walk - dars.gov.et
PolyPid Ltd. (PYPD) Slips 2.27% to $4.73 as Shares Test Key Support ZoneWyckoff Distribution - vinanet.vn
HC Wainwright Issues Negative Estimate for PolyPid Earnings - MarketBeat
PolyPid Ltd. (PYPD) Slips 2.27% to $4.73 as Shares Test Key Support ZoneWedge Breakout - dars.gov.et
PolyPid Ltd. (PYPD) Slips 2.27% to $4.73 as Shares Test Key Support ZoneGEX Level - careplusvn.com
PolyPid Ltd. (PYPD) Slips 2.27% to $4.73 as Shares Test Key Support ZoneDaily Profile - https://www.dars.gov.et/
PolyPid Ltd. (PYPD) Slips 2.27% to $4.73 as Shares Test Key Support ZoneWedge Breakout - dars.gov.et
PolyPid Earnings Call: Priority Review, Big Azurity Deal - TipRanks
PolyPid Ltd (PYPD) (Q2 2026) Earnings Call Highlights: FDA Priority Review and $30M Azurity ... - Yahoo Finance
PolyPid Posts Wider H1 2026 Loss as Assets and Equity Decline - TipRanks
PolyPid Ltd. Q2 2026 Earnings Call Summary - Yahoo Finance
PolyPid (PYPD) secures $30M Azurity payments but flags going concern risk - Stock Titan
Transcript : PolyPid Ltd., Q2 2026 Earnings Call, Aug 12, 2026 - marketscreener.com
Rosalind entities (PYPD) report 9.9% PolyPid stake, with 4.56M warrant shares blocked at 9.99% - Stock Titan
PolyPid Releases Q2 2026 Financial Results - AlphaStreet
PolyPid (NASDAQ:PYPD) Announces Quarterly Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
PolyPid Q2 Earnings Call Highlights - NewsBreak: Local News & Alerts
PolyPid Q2 Earnings Call Highlights - MarketBeat
PolyPid Q2 Earnings Call Highlights - MarketBeat
PolyPid Q2 Earnings Call Highlights - TradingView
PolyPid Q2 losses narrow 55%, FDA accepts D-PLEX100 NDA - scanx.trade
Earnings call transcript: PolyPid narrows loss in Q2 2026 as stock falls premarket - Investing.com Australia
Earnings call transcript: PolyPid narrows loss in Q2 2026 as stock falls premarket - Investing.com India
Earnings call transcript: PolyPid narrows loss in Q2 2026 as stock falls premarket - Investing.com Canada
Earnings call transcript: PolyPid narrows loss in Q2 2026 as stock falls premarket - Investing.com
PolyPid Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: PolyPid narrows loss in Q2 2026 as stock falls premarket - Investing.com
3.09%
0.72%
大文字化:
|
ボリューム (24 時間):